Top 25 X4 Pharmaceuticals investors
The most complete profiles first. Showing 25 of 25.
David BonitaVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more
Verified email available
Geoffrey HsuVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Ken HaasVerified
Venture Capital, Advisor, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
andrew sinclairVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Jonathan CopeVerified
Venture Capital · United States
Health CareWomen FoundedEnterprise SoftwareLife SciencePortfolio: Nuo Therapeutics, X4 Pharmaceuticals, Ocata Therapeutics, Lightwave Logic and 10 more
Verified email available
Jonathan SilversteinVerified
Private Equity Firm · United States
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jonathan WangVerified
Private Equity Firm · China
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Richard VogelVerified
Venture Capital · United States
Health CareWomen FoundedEnterprise SoftwareLife SciencePortfolio: Nuo Therapeutics, X4 Pharmaceuticals, Ocata Therapeutics, Lightwave Logic and 10 more
Verified email available
Rishi GuptaVerified
Private Equity Firm · United States
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Shelley ChuVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Tim HainesVerified
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Trevor DavisVerified
Venture Capital · United States
Health CareWomen FoundedEnterprise SoftwareLife SciencePortfolio: Nuo Therapeutics, X4 Pharmaceuticals, Ocata Therapeutics, Lightwave Logic and 10 more
Verified email available
Bali Muralidhar
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 69 more
Contact details available
Brian Gallagher, Jr.
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin and 67 more
Contact details available
Carter Neild
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Chau Khuong
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more
Contact details available
Kurt von Emster
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedInvestment ManagementLife SciencePortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Scotland Stevens
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Vin Miles
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Anat Naschitz
Private Equity Firm · Israel
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Erez Chimovits
Private Equity Firm · Israel
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
John Heard
Venture Capital, Private Equity Firm · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Oscar Palmer
Venture Capital · United States
Health CareWomen FoundedEnterprise SoftwareInvestment ManagementPortfolio: Nuo Therapeutics, X4 Pharmaceuticals, Ocata Therapeutics, Lightwave Logic and 10 more
Contact details available
Robert Garcia
Venture Capital · United States
Health CareWomen FoundedEnterprise SoftwareInvestment ManagementPortfolio: Nuo Therapeutics, X4 Pharmaceuticals, Ocata Therapeutics, Lightwave Logic and 10 more
Contact details available
Sarah Shackelton
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Scorpion Therapeutics20
- Verona Pharma20
- Q32 Bio20
- Effector Therapeutics10
- CoreMap10
- ReCode Therapeutics10
- GammaDelta Therapeutics10
- Valeritas10
- Harbour Biomed10
- Clover Biopharmaceuticals10
- PrimeraDx (Primera Biosystems)10
Frequently asked questions
How many X4 Pharmaceuticals investors are on Angel Roster?
Angel Roster lists 25 X4 Pharmaceuticals investors. 12 of them (48%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (20), Private Equity Firms (14) and Advisor Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do X4 Pharmaceuticals investors invest in?
Among those that list a stage, the most common are Series B (6), Series A (5) and Seed (5).
Where are X4 Pharmaceuticals investors based?
Most are based in the United States (17), the United Kingdom (5) and Israel (2).
Which companies have X4 Pharmaceuticals investors backed?
The most-backed portfolio companies among them are Scorpion Therapeutics (20), Verona Pharma (20), Q32 Bio (20), Effector Therapeutics (10) and CoreMap (10).
How do I contact X4 Pharmaceuticals investors?
Create a free Angel Roster account to search and filter all 25, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.